Darbitop Injection
Manufacturer
Alniche Life Sciences Pvt Ltd
Salt Composition
Darbepoetin alfa (60mcg)
Key Information
Short Description
Darbitop Injection is used to treat anemia caused by chronic kidney disease or chemotherapy by stimulating the bone marrow to produce more red blood cells.
Dosage Form
Injection
Introduction
Darbitop Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional. Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures). Your doctor may get your blood tests done regularly to monitor the levels of salts (electrolytes such as potassium), hemoglobin, and blood cells in your blood. You should stop taking it and consult with a doctor if you develop shortness of breath or skin rash. Before taking Darbitop Injection, tell your doctor if you have heart disease, high blood pressure, or have had a seizure or stroke. If you are pregnant or breastfeeding, or plan to become pregnant or breastfeed, consult your doctor to make sure it is safe for you.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Safety Information
Side Effects
Abdominal pain High blood pressure Rash Injection site pain Breathlessness Cough Peripheral edema
Alcohol Warning
It is not known whether it is safe to consume alcohol with Darbitop Injection. Please consult your doctor.
Breastfeeding Warning
Darbitop Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Darbitop Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Darbitop Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.
Quick Tips
Darbitop Injection helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy. It is given as a single injection under your skin It can be given intravenously. Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells, in your blood.
Frequently asked questions
How long does it take for Darbitop Injection to start working?
You may notice an increase in your red blood cell count (hemoglobin levels) within 2-6 weeks of starting Darbitop Injection. If you have any concerns, consult your doctor.
Is Darbitop Injection safe to use?
Darbitop Injection is a medication that requires careful consideration as it can lead to serious side effects and even death in some individuals. It's crucial that you seek treatment under the guidance of an experienced healthcare professional who is familiar with Darbitop Injection therapy. Always follow all directions provided precisely.
Are there other reasons for not responding to Darbitop Injection besides PRCA?
You may not respond to Darbitop Injection if you have iron, folic acid, or vitamin B12 deficiencies. It's essential that you address these deficiencies through proper treatment. Other potential reasons for the treatment's lack of effectiveness could be bleeding, infections, inflammation, and bone marrow fibrosis. Please consult your doctor regarding any further concerns.
Can Darbitop Injection be used in children?
Darbitop Injection is used to treat anemia associated with chronic kidney disease in children who are at least one year old. Its effectiveness and potential side effects in children are similar to those observed in adults, but consult your doctor if you have any doubts.
Can Darbitop Injection affect blood pressure?
Yes, Darbitop Injection can influence blood pressure. During the initial stages of treatment with Darbitop Injection, your blood pressure should be closely monitored. For individuals with high blood pressure, it is essential to take appropriate steps for controlling their blood pressure. Your doctor might stop Darbitop Injection if the blood pressure remains uncontrolled.
Who should not take Darbitop Injection?
Individuals with cancer who have not been prescribed Darbitop Injection by their doctor should avoid taking it. Additionally, patients with uncontrolled high blood pressure (hypertension), those with a history of anemia called pure red cell aplasia (PRCA) that starts after treatment with Darbitop Injection or other erythropoietin medications, and individuals with a history of a serious allergic reaction to this medication should not use Darbitop Injection.
